Fox Chase Cancer Center Welcomes Dr Alexander R. Vartanov

Author(s):

Key Takeaways

Alexander R. Vartanov, MD, joins Fox Chase Cancer Center as an assistant professor in Bone Marrow Transplant and Cellular Therapies.
Vartanov completed his Hematology/Oncology Fellowship at Fox Chase and internal medicine residency at the University of Connecticut.
He holds a medical degree from the American University of the Caribbean and a Master of Applied Science from Johns Hopkins.
Vartanov has produced over 25 abstracts, poster presentations, and publications, focusing on lymphoma and leukemia research.
He is affiliated with major hematology and oncology societies and has received several prestigious awards for his research contributions.

Fox Chase Cancer Center hired Alexander R. Vartanov, MD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

Alexander R. Vartanov, MD

Fox Chase Cancer Center is pleased to announce the hiring of Alexander R. Vartanov, MD, as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

Vartanov is joining the department on the heels of his completion of the Fox Chase Hematology/Oncology Fellowship Training Program. Prior to that, he was a resident in internal medicine at the University of Connecticut School of Medicine.

Vartanov earned his medical degree from the American University of the Caribbean School of Medicine and a Master of Applied Science degree, in which his work focused on spatial analysis for public health, from Johns Hopkins University.

Since 2011, Vartanov has produced over 25 abstracts, poster presentations, and peer-reviewed publications. His work covers a variety of subject areas, including lymphoma and leukemia. He also held various clinical research positions at the Dana-Farber Cancer Institute in Boston prior to medical school.

Vartanov is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. He is also the recipient of several awards, including the Abstract Achievement Award from the American Society of Hematology Annual Meeting in 2019. In 2022, he received an In Vino Vita Young Investigator Award from Fox Chase to further his research on the use of steroids in patients being treated for lymphoma.